G J Mufti

Myelodysplastic syndromes: a scoring system with prognostic significance

G J Mufti, Jasper Stevens, David Oscier et al. · British Journal of Haematology · 1985 · 517 citations

Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin

JW Janssen, Michael Buschle, Mark Layton et al. · Blood · 1989 · 307 citations · Full text

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

David A. Sallman, Rami S. Komrokji, Christine Vaupel et al. · Leukemia · 2015 · 226 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Genetics +6

Immunological abnormalities in myelodysplastic syndromes I. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIES

G J Mufti, Ann Figes, Terry J. Hamblin et al. · British Journal of Haematology · 1986 · 187 citations

Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia

Jane E. Parker, Antonio Pagliuca, Aleksandar Mijović et al. · British Journal of Haematology · 1997 · 164 citations · Full text